South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Novo Nordisk A/S can intervene in a lawsuit between the FDA and drug compounders over whether its blockbuster drugs Wegovy ...
As part of its ongoing efforts to ensure patients who need Wegovy, or semaglutide, injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg can ...
Novo Nordisk (NVO) is advancing 4% after the drug maker cut the price of its very popular weight-loss drug, Wegovy, by over ...
Dave Moore, Executive Vice President of U.S. Operations and Global Business Development at Novo Nordisk, noted that while ...
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), The Coca-Cola ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback